Aomics GmbH

Technologies Expertise

We provide a wide range of Services using the following technologies

Technologies under development

Phase-1

Conceptualization

Phase-2

Proof of Concept

Phase-3

Testing & Validation

Phase-4

Launch & Marketing

Phase-5

Scaling & Establishing

MULTIOMICS-AI
Multi-omics based AI pipeline
Clinic-Ledger- Blockchain platform
AI/Blockchain for orphan drugs clinical trials
AI-RARE
AI based orphan drug development pipeline

Compounds in Pipeline

Target Indication

Diseases of the nervous system

Congenital malformations, deformations and chromosomal abnormalities

Endocrine, nutritional and metabolic diseases

Diseases of the circulatory system

 Atherosclerosis (CVD)

Discovery/Research

Preclinical

Clinical PoC Trials

Clinical Trial
Phase-I

Clinical Trial
Phase-II

Clinical Trial
Phase-III

NDA Filed
(FDA filing)

AOM-Rare-20191
AOM-Rare-20201
AOM-Rare-20211
AOM-Rare-20212
AOM-CVD-20213

Which technologies we apply for accomplishing drug discovery and pipeline development?

AI/ML Development

Application Development

Blockchain Development

Blockchain_Technology

Would you like to start a project with us?

Reach out on the given number or write us an email for further queries regarding project requirements